[1]
D. T. Majid, A. Ermanda, D. N. Aisyah, U. D. Padli, M. A. Abdulloh, and S. Ikram, “THE EFFECT OF CORPORATE SOCIAL RESPONSIBILITY DISCLOSURE AND PROFITABILITY ON FIRM VALUE (Survey on Pharmaceutical Industry Companies Listed on the IDX)”, CAC, vol. 23, no. 1, pp. 4409–4417, Jan. 2022, Accessed: Nov. 23, 2024. [Online]. Available: https://ca-c.org/CAC/index.php/cac/article/view/435